相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability
Marek Malik et al.
HEART RHYTHM (2011)
Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies
Jeffry A. Florian et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Creation of a Knowledge Management System for QT Analyses
Christoffer W. Tornoe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit
Ingemar Jacobson et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2011)
The Cardiac Safety Research Consortium electrocardiogram warehouse: Thorough QT database specifications and principles of use for algorithm development and testing
Paul Kligfield et al.
AMERICAN HEART JOURNAL (2010)
Electrocardiographic assessment for therapeutic proteins-scientific discussion
Ignacio Rodriguez et al.
AMERICAN HEART JOURNAL (2010)
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development
Sherene S. Min et al.
AMERICAN HEART JOURNAL (2010)
Statistical Characteristics of Moxifloxacin-Induced QTc Effect
Lihan K. Yan et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2010)
PharmGKB very important pharmacogene: SLCO1B1
Connie Oshiro et al.
PHARMACOGENETICS AND GENOMICS (2010)
Assessing proarrhythmic potential of drugs when optimal studies are infeasible
Edwin P. Rock et al.
AMERICAN HEART JOURNAL (2009)
International life sciences institute (health and environmental sciences institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes
A. S. Bass et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Testing for positive control activity in a thorough QTc study
Joanne Zhang
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2008)
Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review
Christine E. Garnett et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Torsades de pointes liability inter-model comparisons: The experience of the QT PRODACT initiative
Keitaro Hashimoto
PHARMACOLOGY & THERAPEUTICS (2008)
Cardiac repolarisation and drug regulation - Assessing cardiac safety 10 years after the CPMP guidance
Rashmi R. Shah
DRUG SAFETY (2007)
The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France
Pascale Olivier et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets
A Clarke et al.
DRUG SAFETY (2006)
Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes
C Antzelevitch et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Can pharmacogenetics help rescue drugs withdrawn from the market?
Rashmi R. Shah
PHARMACOGENOMICS (2006)
QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder
DB Serra et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Clinical assessment of drug-induced QT prolongation in association with heart rate changes
F Extramiana et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
ML De Bruin et al.
EUROPEAN HEART JOURNAL (2005)
QT PRODACT: A multi-site study of in vitro action potential assays on 21 compounds in isolated guinea-pig papillary muscles
S Hayashi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Drug-induced Torsades de Pointes and implications for drug development
RR Fenichel et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Evaluation of Vardenafil and Sildenafil on cardiac repolarization
J Morganroth et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Electrocardiographic identification of drug-induced QT prolongation: Assessment by different recording and measurement methods
N Sarapa et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2004)
Drug-induced QT interval prolongation: regulatory perspectives and drug development
RR Shah
ANNALS OF MEDICINE (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management
ME Anderson et al.
AMERICAN HEART JOURNAL (2002)
Practitioner acceptance of the dofetilide risk-management program
NMA LaPointe et al.
PHARMACOTHERAPY (2002)
Prolongation of repolarization in pre-clinical investigations and phase I/II clinical trials: what should be done?
G Sponer
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
Focus on issues in measuring and interpreting changes in the QTc interval duration
J Morganroth
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
Drug-induced torsade de pointes: the perspectives of industry
L Carlsson
EUROPEAN HEART JOURNAL SUPPLEMENTS (2001)
Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey
TG Hammond et al.
CARDIOVASCULAR RESEARCH (2001)
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications - Report on a Policy Conference of the European Society of cardiology
W Haverkamp et al.
EUROPEAN HEART JOURNAL (2000)
Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride:: in vitro studies of potential co-medication interactions
H Bohets et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
